Table 4 |
||||||
|
Incidence and disease burden calculated with and without the preference-based relevance criterion (RC), by pathogen |
||||||
|
Without RC |
With RC |
|||||
|
|
||||||
|
Pathogen |
Incidence |
YLL |
YLD |
DALY |
YLD |
DALY |
|
|
||||||
|
Norovirus |
||||||
|
Gastroenteritis |
472,000 |
55 |
2885 |
2940 |
121 |
175 |
|
Rotavirus |
||||||
|
Gastroenteritis |
190,000 |
110 |
1217 |
1327 |
176 |
287 |
|
Thermophilic Campylobacter spp. |
||||||
|
Gastroenteritis |
59,400 |
390 |
420 |
810 |
148 |
538 |
|
Guillain-Barré syndrome |
60 |
35 |
150 |
185 |
150 |
185 |
|
Reactive arthritis |
864 |
- |
40 |
40 |
40 |
40 |
|
Inflammatory Bowel Disease |
22 |
- |
102 |
102 |
102 |
102 |
|
Total |
1137 |
865 |
||||
|
Salmonella spp. |
||||||
|
Gastroenteritis |
35,400 |
440 |
255 |
697 |
77 |
517 |
|
Reactive arthritis |
460 |
- |
17 |
17 |
17 |
17 |
|
Inflammatory Bowel Disease |
7 |
- |
33 |
33 |
33 |
33 |
|
Total |
747 |
567 |
||||
|
STEC O157 |
||||||
|
Gastroenteritis |
1,300 |
6 |
13 |
19 |
7 |
13 |
|
Hemolytic Uremic Syndrome |
20 |
76 |
25 |
101 |
25 |
101 |
|
Total |
120 |
114 |
||||
|
|
||||||
|
Haagsma et al. Population Health Metrics 2008 6:7 doi:10.1186/1478-7954-6-7 |
||||||
